Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2011 | ||||||||
|
acyl-CoA dehydrogenase very long chain | 0.653 | 0.654 | 4.2E-15 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
aldolase, fructose-bisphosphate A | 0.631 | 0.615 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.300 | None | 0.923 | 1 | 0 | 2001 | 2019 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
disease | 0.300 | None | 0.950 | 1 | 0 | 2003 | 2019 | ||||||||
|
ATPase H+/K+ transporting non-gastric alpha2 subunit | 0.575 | 0.769 | 7.1E-14 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2017 | 2018 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
disease | 0.300 | None | 0.958 | 1 | 0 | 1999 | 2019 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
cytochrome b-245 alpha chain | 0.520 | 0.769 | 8.9E-06 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
epoxide hydrolase 2 | 0.568 | 0.654 | 1.8E-21 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2012 | 2014 | ||||||||
|
Fas associated via death domain | 0.537 | 0.846 | 0.53 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
fibroblast growth factor 19 | 0.548 | 0.615 | 0.57 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2017 | 2018 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2009 | 2014 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2010 | 2020 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
histone deacetylase 3 | 0.511 | 0.731 | 0.57 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
hydroxysteroid 11-beta dehydrogenase 1 | 0.520 | 0.731 | 0.42 |
|
disease | 0.300 | None | 0.857 | 1 | 0 | 2004 | 2019 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.270 | None | 1.000 | 1 | 0 | 2001 | 2017 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1999 | 2019 |